Literature DB >> 21917961

Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.

Nina Orlova1, Fred Wang, Mark H Fogg.   

Abstract

We examined the CD8(+) T cell repertoire against lytic infection antigens in rhesus macaques persistently infected with the Epstein-Barr virus (EBV)-related lymphocryptovirus (rhLCV). CD8(+) T cells specific for late (L) antigens were detected at rates comparable to those for early antigens and were associated with increasing duration of infection. L antigen-specific CD8(+) T cells were also readily detected in adult, EBV-positive humans. Thus, viral major histocompatibility complex class I (MHCI) immune evasion genes expressed during lytic LCV infection do not prevent L-specific CD8(+) T cell development over time during persistent infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917961      PMCID: PMC3209403          DOI: 10.1128/JVI.05742-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Further characterization of a herpesvirus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate herpesviruses.

Authors:  H Rabin; R H Neubauer; R F Hopkins; M Nonoyama
Journal:  Int J Cancer       Date:  1978-06-15       Impact factor: 7.396

2.  The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.

Authors:  Mark H Fogg; Amitinder Kaur; Young-Gyu Cho; Fred Wang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.

Authors:  M D Catalina; J L Sullivan; K R Bak; K Luzuriaga
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

4.  Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Authors:  A Apolloni; T B Sculley
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

5.  Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; D Dukers; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.

Authors:  Pierre Rivailler; Hua Jiang; Young-gyu Cho; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

Authors:  T B Sculley; A Apolloni; L Hurren; D J Moss; D A Cooper
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

8.  Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.

Authors:  Y G Cho; A V Gordadze; P D Ling; F Wang
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Authors:  C M Rooney; C A Smith; C Y Ng; S Loftin; C Li; R A Krance; M K Brenner; H E Heslop
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

10.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.

Authors:  Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

View more
  6 in total

1.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

2.  CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Authors:  R M Leskowitz; X Y Zhou; F Villinger; M H Fogg; A Kaur; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

3.  CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response.

Authors:  Rachel J M Abbott; Laura L Quinn; Alison M Leese; Harry M Scholes; Annette Pachnio; Alan B Rickinson
Journal:  J Immunol       Date:  2013-10-21       Impact factor: 5.422

4.  Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Authors:  Marissa Herrman; Janine Mühe; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

5.  An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Authors:  Makoto Ohashi; Mark H Fogg; Nina Orlova; Carol Quink; Fred Wang
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

6.  Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection.

Authors:  Calum Forrest; Andrew D Hislop; Alan B Rickinson; Jianmin Zuo
Journal:  PLoS Pathog       Date:  2018-09-24       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.